215 related articles for article (PubMed ID: 25212524)
1. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets.
Zhou T; Zhang B; Wei P; Du Y; Zhou H; Yu M; Yan L; Zhang W; Nie G; Chen C; Tu Y; Wei T
Biomaterials; 2014 Dec; 35(37):9833-9843. PubMed ID: 25212524
[TBL] [Abstract][Full Text] [Related]
2. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
[TBL] [Abstract][Full Text] [Related]
3. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
4. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
5. Selective Accelerated Proliferation of Malignant Breast Cancer Cells on Planar Graphene Oxide Films.
Kenry ; Chaudhuri PK; Loh KP; Lim CT
ACS Nano; 2016 Mar; 10(3):3424-34. PubMed ID: 26919537
[TBL] [Abstract][Full Text] [Related]
6. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
[TBL] [Abstract][Full Text] [Related]
7. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
8. Positively charged graphene oxide nanoparticle: precisely label the plasma membrane of live cell and sensitively monitor extracellular pH in situ.
Zhu H; Gao L; Jiang X; Liu R; Wei Y; Wang Y; Zhao Y; Chai Z; Gao X
Chem Commun (Camb); 2014 Apr; 50(28):3695-8. PubMed ID: 24575428
[TBL] [Abstract][Full Text] [Related]
9. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.
Yang YY; Zhang W; Liu H; Jiang JJ; Wang WJ; Jia ZY
Drug Des Devel Ther; 2021; 15():4961-4972. PubMed ID: 34916779
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.
Lan MY; Hsu YB; Lan MC; Chen JP; Lu YJ
Int J Nanomedicine; 2020; 15():7569-7582. PubMed ID: 33116488
[TBL] [Abstract][Full Text] [Related]
14. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
15. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
16. Antitumor Effect of GO-PEG-DOX Complex on EMT-6 Mouse Breast Cancer Cells.
Yan J; Song B; Hu W; Meng Y; Niu F; Han X; Ge Y; Li N
Cancer Biother Radiopharm; 2018 May; 33(4):125-130. PubMed ID: 29763376
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration.
Zhou H; Zhang B; Zheng J; Yu M; Zhou T; Zhao K; Jia Y; Gao X; Chen C; Wei T
Biomaterials; 2014 Feb; 35(5):1597-607. PubMed ID: 24290441
[TBL] [Abstract][Full Text] [Related]
18. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
[TBL] [Abstract][Full Text] [Related]
19. Graphene Oxide Nanosheets Retard Cellular Migration via Disruption of Actin Cytoskeleton.
Tian X; Yang Z; Duan G; Wu A; Gu Z; Zhang L; Chen C; Chai Z; Ge C; Zhou R
Small; 2017 Jan; 13(3):. PubMed ID: 27762498
[TBL] [Abstract][Full Text] [Related]
20. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
